Mergent Online

Nektar Therapeutics (NAS: NKTR)+ to Company Analysis List

Address: 455 Mission Bay Boulevard South,San Francisco, CA 94158 United States | Phone: 415 482-5300 | Company Website: www.nektar.com

Incorporated: July 1990 , CA, United States

Reincorporated: July 1998 , DE, United States

IRS Number: 943134940

Auditor: Ernst & Young LLP

Legal Counsel: O’Melveny & Myers LLP

Transfer Agent: Computershare Shareowner Services LLC, Jersey City, NJ

Country: United States

Industry: Biotechnology (ICB 20103010)

Industry: Pharmaceutical preparations (SIC 2834)

Industry: Pharmaceutical Preparation Manufacturing (NAICS 325412)

Number of Employees: 216 (Year End Average Staff as of 12/31/2022)

Number of Shareholders: 148 (approx. record) (as of 02/21/2023)

Market Cap: 242,984,280

Revenue: 93,157,000

Net Income: -177,081,000

EPS Basic: -0.9 EPS Diluted: -0.9

	Company Analysis List (0/500)
	No company added to the Company Analysis List

	Executive List (0/500)
	No executive added to the Executive List

	Mergent Private Company List (0/500)
	No company added to the Mergent Private Company List

	Company Alerts (0)
	No alerts added to Alerts

	Executive Alerts (0)
	No alerts added to Executive Alerts

Sector	Focused / Sector Pure-Play	Companies
Healthcare		6860
Biopharmaceuticals		2429
Dermatology		536
Digestive System		785
Endocrinology/Metabolism		716
Hematology		548
Immunology		688
Musculoskeletal System		431
Oncology		1004
Ophthalmology		317
Urology		414
Outsourced Biomedical Services		1661
Drug Delivery Technology		55

Note:	- Focused. Denotes that the company is considered focused in this area. In general, Focused Companies draw the majority of their earnings in the sector/product area specified. - Sector Pure-Plays. Denotes that the company is focused in the selected sector and has no presence in any other branch of the Revere Hierarchy.

Mergent, Inc